Prevalence of Novel Risk Factors in Patients of Acute Coronary Syndrome in Eastern India: A Detailed Analysis


  • Sudeb Mukherjee R G Kar Medical College & Hospital
  • Kaushik Manna Calcutta National Medical College & Hospital
  • Suhana Datta R G Kar Medical College & Hospital



Background: To  identify  prevalence  of   the  novel  risk  factors  among  young  patients   with  Acute  Coronary  Syndrome  (ACS)  and  having  no  or  minimal  conventional  risk factors.

Methods: Total  70  patients  ( male  48 ,  female 22 )   who  were  admitted  in  our  hospital with  ACS,  without  any  traditional  risk  factors  were  analyzed  for  hsCRP  [highly  sensitive  C  reactive  protein ],  Lp(a)  [Lipoprotein(a)],  Homocysteine  and  uric  acid  level.

Results: 44.29%  of  the  study  population  have  high  values  of  hs-CRP,  more  in  older age  group  but  not  significant (<40 vs >40 yrs) (P=0.79). High  homocysteine  present in 42.86%  of cases,  more  in  older  age ( >40 yrs) (54.55%)  than  <40  years  age  (23.08%) which  is  statistically  significant  (P-0.01).  High  uric  acid  level  found  in  32.86%  of cases  without  any  significant  age  and  sex  difference.  High  Lp(a)  level  is  found  in 41.43%  of  cases  more  among ≥40  years (50%)  than  <40 years (26.92%),  the  difference was  not  found  to  be  statistically  significant. [ Chi-square = 3.587; P=0.058; OR=2.71 95%  CI= 0.95 – 7.7].

Conclusion:  hsCRP  is  most  useful  cost  effective  screening  method  for  ACS  in younger  individual  among  all  other  parameters  in  this  part  of  world .

Author Biographies

Sudeb Mukherjee, R G Kar Medical College & Hospital

MD (Medicine), Department of Medicine.

Kaushik Manna, Calcutta National Medical College & Hospital

MD,(Medicine), Senior Resident, Department of Cardiology.

Suhana Datta, R G Kar Medical College & Hospital

MBBS , Junior Residnt, Department Of Medicine


Ridker PM. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem. 2009 Feb;55(2):209-15. doi: 10.1373/clinchem.2008.119214

Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.J Am Coll Cardiol. 2007;49: 2129-138. doi :10. 1016/ j.jacc. 2007.02.052.

Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ.: C-reactive protein and reclassification of cardiovascular risk in the Framingham heart study. Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):92-7. doi: 10.1161 / Circoutcomes.108.831198

Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Rush D, Schaefer EJ, Rosenberg IH. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. J Nutr. 1996 Apr;126(4 Suppl):1258S-65S

Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocysteine and ischemic stroke due to large and small artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000: May;31(5):1069-75

Evers S, Koch HG, Grotemeyer KH, Lange B, Deufel T, Ringelstein EB: Features, symptoms, and neurophysiological findings in stroke associsted with hyperhomocysteinemia. Arch Neurol 1997; 54: 1276-82.

Tsai JC, Wang H, Perrella MA, Yoshizumi M, Sibinga NE, Tan LC, Haber E, Chang TH, Schlegel R, Lee ME.; Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97:146-53.

Den Heijer M, Koster T, Blom HJ, Bos GM, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–62.

Wall RT, Harlan JM, Harker LA, Striker GE: Homocysteine induced endothelial cell injury in vitro: A model for study of vascular injury. Thrombo Res 1980; 18:113-21.

Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease: N Engl J Med. 2005 Jul 7;353(1):46-57. doi: 10. 1056 /NEJM oa 043175

Suk Danik J, Rifai N, Buring JE, Ridker PM: Lipoproteine(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 296:1363, 2006. doi: 10.1001/jama.296.11.1363

Shao-Yuan Chuang; Jonathan Jiunn-Horng Chen; Chih-Cheng Wu; Wen-Harn Pan Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. International Journal of Cardiology , Volume 154 , Issue 3 , 316 – 321. doi:

American Heart Association/American Stroke Association Statistical data on Heart disease & Stroke Update 2015.

Gupta R, Gupta VP. Meta-analysis of coronary heart disease prevalence in India. Indian Heart J 1996;48:241-5.

Prabhakaran D, Yusuf S, Mehta S, Pogue J, Avezum A, Budaj A, Cerumzynski L, Flather M, Fox K, Hunt D, Lisheng L, Keltai M, Parkhomenko A, Pais P, Reddy S, Ruda M, Hiquing T, Jun Z . Two-year outcomes in patients admitted with non-ST elevation,acute coronary syndrome: results of the OASIS registry 1 and 2. Indian Heart J ,2005; 57: 217-25

Sharma M, Ganguly NK. Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag, 2005; 1: 217-25.

Enas EA, Yusuf S, Mehta J. Meeting of the International Working Group on Coronary Artery Disease in South Asians. 24 March 1996, Orlando, Florida, USA. Indian Heart J 1996;48:727-32

Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data: Denis Xavier, Prem Pais, PJ Devereaux, Changchun Xie, D Prabhakaran, K Srinath Reddy, Rajeev Gupta, Prashant Joshi, Prafulla Kerkar, S Thanikachalam, KK Haridas, TM Jaison, Sudhir Naik, AK Maity, Salim Yusuf; The Lancet , Volume 371 , Issue 9622, 1435 - 1442 ,2008.

Gupta S, Gupta VK, Gupta R, Arora S, Gupta V. Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: An Indian perspective. Indian Heart Journal. 2013;65(3):359-365. doi: 10.1016 /j. ihj. 2013 .04.035.

Ankur Gupta, Dinesh K Badyal, Prem P Khosla, Bharti Uppal, Thannikot M Jaison, Sandeep Chopra : “Effect of Atorvastatin on Hs-CRP in Acute Coronary Syndrome.” British Journal of Clinical Pharmacology 66.3 (2008): 411–413. doi: 10.1111/j.1365-2125.2008.03172.x

Oudi M. E., Aouni, Z., Mazigh, C., Khochkar, R., Gazoueni, E., Haouela, H., & Machghoul, S. (2010). Homocysteine and markers of inflammation in acute coronary syndrome. Experimental & Clinical Cardiology, 15(2), e25–e28






Original Article